NeXT Personal™ for Ultra-sensitive Minimal Residual Disease (MRD) Detection & Response Monitoring
Time: 2:00 pm
day: Day One Track A PM
Details:
- NeXT Personal is an advanced tumor-informed liquid biopsy assay with superior sensitivity and specificity in measuring MRD
- Case studies in the Immunotherapy setting establish a strong correlation of NeXT Personal MRD with clinical outcome
- New clinical evidence from TRACERx demonstrates the significance of NeXT Personal in early-stage lung cancer and how ultra-sensitivity matters
